Xi'an ruixi Biological Technology Co

Home > Keywords >

Catalog	name	Description	price
R-C-1127	KPT 9274 ( ATG-019) CAS:1643913-93-2	KPT-9274,also known as PAK4-IN-1,is a potent,selective and dual PAK4/NAMPT inhibitor.KPT-9274 interferences with PAK4/NAMPT signaling pathways, which results in reduction of G2-M transit as well as induction of apoptosis and decrease in cell invasion and migration in several human RCC cell lines. Mechanistic studies demonstrate that inhibition of the PAK4 pathway by KPT-9274 attenuates nuclear β-catenin as well as the Wnt/β-catenin targets cyclin D1 and c-Myc.	price>
R-C-2827	DSPE-PEG1K-3,5-Diiodo-DL-tyrosine	PEG lipid conjugate DSPE peg is not only widely used as a self-assembly material for anticancer drug delivery,but also as an additive material for surface functionalization of various drug delivery systems.Dl-3,5-diiodine tyrosine is flake crystal.Decompose at about 200 ℃.Solubility in water: 0.149g/l at 0 ℃,0.340g/l at 25 ℃ and 0.773g/l at 50 ℃. Soluble in dilute alkali.	price>
R-R-2827	GLP-1 moiety from Dulaglutide CAS No.1197810-60-8	GLP-1 moiety from Dulaglutide/CAS No.1197810-60-8 is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist, extracted from patent US 20160369010 A1.	price>
R-C-1128	SAR191801 CAS:1234708-04-3	SAR191801 is a hPGDS inhibitor ,with IC50 of 12 nM in the Fluorescence Polarization Assay or the EIA assay.	price>
R-C-2828	PLGA-PEG-Hyaluronate	Hyaluronic acid is a kind of high molecular polymer.It is an advanced polysaccharide composed of unit D-glucuronic acid and N-acetylglucosamine. Between D-glucuronic acid and N-acetylglucosamine β- 1,3-glycosylation bond is connected, and the disaccharide units are connected by β- 1, 4-glycosylation bond.PLGA-PEG is one of the most commonly used biodegradable ABC polymers for drug delivery.Biotin can bind to avidin and streptavidin with high specificity and affinity.	price>
R-R-2828	GLP-1R agonist 2 CAS No.281209-71-0	GLP-1R agonist 2 (compound 2)/CAS No.281209-71-0 is a potent GLP-1R agonist. GLP-1R agonist 2 has the potential for the research of metabolic diseases like Type2 Diabetes and Obesity.	price>
R-C-1129	Baricitinib(LY3009104) CAS :1187594-09-7	Baricitinib(LY3009104,INCB028050)is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM in cell-free assays,~70 and ~10-fold selective versus JAK3 and Tyk2,no inhibition to c-Met and Chk2.	price>
R-C-2829	DSPE-PEG2K-CGSPGWVRC-FITC	Targeted polypeptide is a promising delivery ligand with the advantages of good permeability,convenient synthesis,low immunogenicity,low cost and easy modification.Cgspgwvrc is a lung endothelial cell targeted peptide(let) obtained by phage display technology, and its good lung endothelial cell targeting ability has been confirmed by experiments in vitro and in vivo.PEG lipid conjugate DSPE peg is not only widely used as a self-assembly material for anticancer drug delivery,but also as an additive material for surface functionalization of various drug delivery systems.	price>
R-R-2829	Survodutide CAS No.2805997-46-8	Survodutide (BI 456906)/CAS No.2805997-46-8 is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake.	price>
R-C-1130	TAK063 CAS:1238697-26-1	TAK-063,also known as Balipodect.,is a highly potent,selective,and orally active phosphodiesterase 10A(PDE10A)inhibitor.TAK-063 is currently being evaluated in clinical trials for the treatment of schizophrenia.Phosphodiesterase 10A(PDE10A)is a cAMP/cGMP phosphodiesterase highly expressed in medium spiny neurons(MSNs)in the striatum.TAK-063 represents a promising drug for the treatment of schizophrenia with potential for superior safety and tolerability profiles.	price>
R-C-2830	Oil soluble MnxFe3-xO4 nanoparticles	The average autocatalytic reaction order of MnxFe3-xO4 nanoparticles increased from 0.48 of pure epoxy to 0.52 of epoxy/MnxFe3-xO4 nanocomposites, because the hydroxyl groups on the surface of nanoparticles participated in the ring opening of epoxides.	price>
R-R-2830	Glepaglutide acetate	Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide acetate reduces faecal output and increases intestinal absorption. Glepaglutide acetate alleviates small intestinal inflammation.	price>
R-C-1131	SB239063 CAS:193551-21-2	SB 239063 is a selective p38 MAPK inhibitor(IC50=44 nM for recombinant purified p38α).1 It displays greater than 220-fold selectivity for p38 MAPK over ERK, JNK1,and other kinases.1 SB 239063 has been shown to reduce inflammatory cytokine production in lipopolysaccharide-stimulated human peripheral blood monocytes(IC50s=0.12 and 0.35 µM,respectively for IL-1 and TNF-α)and is neuroprotective following oral administration in a rat model of cerebral focal ischemia.	price>
R-C-2831	Mannose/chitosan loaded on liposome surface(90nm)	Long circulating liposomes can inhibit tumor and regulate immunity Chitosan, a natural polymer,has excellent properties such as biological functionality and compatibility,blood compatibility,safety,microbial degradation and so on.	price>
R-R-2831	GLP-2(3-33) CAS No.275801-62-2	GLP-2(3-33)/CAS No.275801-62-2, generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM).	price>
R-C-1132	BIBX1382 CAS:196612-93-8	BIBX 1382 is a cell-permeable pyrimidopyrimidine compound that acts as a potent, reversible,ATP-competitive,and highly selective inhibitor of EGFR.	price>
R-C-2832	DSPE-NBD	1,2-distearoyl-sn-glycoro-3-phosphoethanolamine-nitrobenzofurazan is produced by Xi an Ruixi biology.Our company can also produce various customized products.	price>
R-R-2832	Glucagon receptor antagonists-3 CAS No.202917-17-7	Glucagon receptor antagonists-3/CAS No.202917-17-7 is a highly potent glucagon receptor antagonist.	price>
R-C-1133	GSKJ1 CAS :1373422-53-7	GSKJ1 is a selective and potent histone demethylase inhibitor(GSK-J1)that has significant activity(IC50 60 nM for human JmjD3)in vitro and in cells using an ester derivative(GSK-J4:1 µM	price>
R-C-2833	PLA5K-PEG2K-Heparin nanoparticles	The former is helpful to improve the biocompatibility,targeting and drug loading of nanoparticles,while the latter is mainly used for the targeted transport of proteins and antitumor drugs.	price>

492493494495496497 498499500501502